Rémy Henri Luthringer
Chief Executive Officer bij MINERVA NEUROSCIENCES, INC.
Vermogen: 476 833 $ op 31-03-2024
Profiel
Rémy Henri Luthringer founded Somno-Art.
Dr. Luthringer also currently works at Minerva Neurosciences, Inc., as Executive Chairman & Chief Executive Officer from 2018, Inexia Ltd., as Director from 2019, and Centessa Pharmaceuticals (Orexia) Ltd., as Director from 2019.
Dr. Luthringer also formerly worked at FORENAP Pharma SARL, as Chief Executive Officer from 2009 to 2014, Mind-NRG SARL, as Director, Index Ventures SA, as Venture Partner from 2010 to 2019, and Index Venture Management (US), Inc., as Chief Medical Officer.
Dr. Luthringer received his graduate degree from Université Pierre et Marie Curie and doctorate degree from the University of Strasbourg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-10-2023 | 184 819 ( 2.64% ) | 476 833 $ | 31-03-2024 |
Actieve functies van Rémy Henri Luthringer
| Bedrijven | Functie | Begin |
|---|---|---|
| MINERVA NEUROSCIENCES, INC. | Chief Executive Officer | 20-11-2014 |
Orexia Therapeutics Ltd.
 Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Orexia Ltd. develop orally administered orexin positive modulators for the treatment of neurological diseases. The company was founded on October 5, 2018 and is headquartered in London, the United Kingdom. | Director/Board Member | 16-04-2019 |
Inexia Ltd.
 Inexia Ltd. Medical SpecialtiesHealth Technology Inexia Ltd. develops intranasal orexin positive modulators for the treatment of narcolepsy. The company is headquartered in London, the United Kingdom. | Director/Board Member | 16-04-2019 |
Eerdere bekende functies van Rémy Henri Luthringer
| Bedrijven | Functie | Einde |
|---|---|---|
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Private Equity Investor | 31-12-2019 |
FORENAP Pharma SARL
 FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Chief Executive Officer | 25-03-2014 |
Index Venture Management (US), Inc.
 Index Venture Management (US), Inc. Investment ManagersFinance Founded in 2011, Index Venture Management (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Index Venture Management SA | Chief Tech/Sci/R&D Officer | - |
Somno-Art
 Somno-Art Medical SpecialtiesHealth Technology Somno-Art manufactures ambulatory medical devices. It offers sleep recording, analysis, and clinical data to doctors and patients. The company was founded by Alain Muzet, Remy Luthringer, and Jean-Yves Schaffhauser and is headquartered in Strasbourg, France. | Founder | - |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Director/Board Member | - |
Opleiding van Rémy Henri Luthringer
| University of Strasbourg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MINERVA NEUROSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Index Ventures SA
Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Finance |
| Université Pierre et Marie Curie | Consumer Services |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Commercial Services |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Health Services |
Index Venture Management (US), Inc.
Index Venture Management (US), Inc. Investment ManagersFinance Founded in 2011, Index Venture Management (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Index Venture Management SA | Finance |
Somno-Art
Somno-Art Medical SpecialtiesHealth Technology Somno-Art manufactures ambulatory medical devices. It offers sleep recording, analysis, and clinical data to doctors and patients. The company was founded by Alain Muzet, Remy Luthringer, and Jean-Yves Schaffhauser and is headquartered in Strasbourg, France. | Health Technology |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Inexia Ltd. develops intranasal orexin positive modulators for the treatment of narcolepsy. The company is headquartered in London, the United Kingdom. | Health Technology |
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Orexia Ltd. develop orally administered orexin positive modulators for the treatment of neurological diseases. The company was founded on October 5, 2018 and is headquartered in London, the United Kingdom. | Commercial Services |
